CJC-1295

Product name: CJC-1295

CAS No.: 87616-84-0

MF:C165H271N47O46

MW: 3649.30

Character:White powder

Assay:98.0%

Place of Origin: China

Standard: Enterprise Standard

Certification: ISO9001

Delivery Time: Within 24h After The Payment Confirm

Supply Ability: 500kg/month

Packaging Details: as requirement

Payment Terms: Western Union, MoneyGram, T/T

Usage

An obstetric drug used to control postpartum hemorrhaging.

Product description

CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are both Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life. Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days. Many a scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural as they produce a short pulse.

Applications

CJC-1295 is an injectable peptide used to increase GH production. This peptide is a hormone releasing hormone (GHRH) mimetic, or analog. That is to say, it works in the same way as GHRH, and may be referred to as being a GHRH.

The principal use of CJC-1295 is to provide increased GH levels, which also results in increased IGF-1 levels. An increase in these levels can aid fat loss and in some instances can aid muscle gain as well. Generally, a product in the GHRH category, including CJC-1295, is chosen as an alternate to using GH, and only rarely is combined with GH.

Contact Details

If you need this or you are interest in this kind of products, you are free to send me email or call me directly, we can talk more about the details of the products.No matter you become a customer to me or not at last, you are welcome to inquire from me!